Hepatitis B virus X protein: Structure, function and biology

Intervirology

Volumn 42, Issue 2-3, 1999, Pages 81-99

  Murakami, Seishi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Modulation; Oncogenic; RNA polymerase; Transactivation; X protein

Indexed keywords

PROTEIN P53; PROTEIN X; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL CYCLE; CELL TRANSFORMATION; DNA REPAIR; GENE ACTIVATION; GENETIC CONSERVATION; HEPATITIS B; HEPATITIS B VIRUS; LIVER CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELL DEATH; DNA REPAIR; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032847032     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024969     Document Type: Review

References (154)

1. Hollinger FB: Hepatitis B virus; in Fields BN, Kinpe DM (eds): Virology. New York, Raven Press, 1990, pp 2171-2338.
2. Yen TSB: Hepadnaviral X protein: Review of recent progress. J Biomed Sci 1996;3:20-30.
3. Tiollais P, Pourcel C, Dejean A : The hepatitis B virus. Nature 1985;317:489-495.
4. Miller RH, Kaneko S, Chung CT, Girones R, Purcell RH: Compact organization of the hepatitis B virus genome. Hepatology 1989;9:322-327.
5. Mizokami M, Orito E, Ohba K, Ikeo K, Lau JY, Gojobori T: Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 1997;44:S83-90.
6. Kodama K, Ogasawara N, Yoshikawa H, Murakami S: Nucleotide sequence of a cloned woodchuck hepatitis virus genome: Evolutional relationship between hepadnaviruses. J Virol 1985;56:978-986.
7. Meyers ML, Trepo LV, Nath N, Sninsky JJ: Hepatitis B virus polypeptide X: Expression in Escherichia coli and identification of specific antibodies in sera from hepatitis B virus-infected humans. J Virol 1986;57:101-109.
8. Pfaff E, Salfeld J, Gmelin K, Schaller H, Theilmann L: Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology 1987;158:456-460.
9. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH: The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993;67:1218-1226.
10. Zoulim F, Saputelli J, Seeger C: Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994;68:2026-2030.
11. Shaul Y, Rutter WJ, Laub O: A human hepatitis B viral enhancer element. EMBO J 1985;4: 427-430.
12. Yee JK: A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 1989;246:658-661.
13. Kaneko S, Miller RH: X-region-specific transcript in mammalian hepatitis B virus-infected liver. Virol 1988;62:3979-3984.
14. Guo WT, Wang J, Tam G, Yen TS, Ou JS: Leaky transcription termination produces larger and smaller than genome size hepatitis B virus X gene transcripts. Virology 1991;181:630-636.
15. Kim CM, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351: 317-320.
16. Zhang P, Raney AK, McLachlan A: Characterization of the hepatitis B virus X-and nucleocapsid gene transcriptional regulatory elements. Virology 1992;191:31-41.
17. Yaginuma K, Nakamura I, Takada S, Koike K: A transcription initiation site for the hepatitis B virus X gene is directed by the promoter-binding protein. J Virol 1993;67:2559-2565.
18. Guo WT, Bell KD, Ou JH: Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol 1991;65:6686-6692.
19. Faktor O, Budlovsky S, Ben-Levy R, Shaul Y: A single clement within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. J Virol 1990;64:1861-1863.
20. Murakami S, Uchijima M, Shimoda A, Kaneko S, Kobayashi K, Hattori N: Hepadnavirus enhancer and its binding proteins. Gastroenterol Jpn 1990;2:11-19.
21. Dikstein R, Faktor O, Ben-Levy R, Shaul Y: Functional organization of the hepatitis B virus enhancer. Mol Cell Biol 1990;10:3682-3689.
22. Faktor O, Shaul Y: The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-1 tax. Oncogene 1990;5:867-872.
23. Guo WT, Bell KD, Ou JH: Characterization of the hepatitis B virus Enh I enhancer and X promoter complex. J Virol 1991;65:6686-6692.
24. Huan B, Siddiqui A: Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer. Proc Natl Acad Sci USA 1992;89:9059-9063.
25. Garcia AD, Ostapchuk P, Hearing P: Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I. J Virol 1993;67:3940-3950.
26. Gustin K, Shapiro M, Lee W, Burk RD: Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis. Virology 1993;193:653-660.
27. Murakami S, Cheong JH, Ohno S, Matsushimi K, Kaneko S: Transactivation of human hepatitis B virus X protein. HBx operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 1994 199:243-246.
28. Ohno H, Kaneko S, Kobayashi K, Murakami S: Human hepatitis B virus enhancer 1 is responsive to human interleukin-6. J Med Virol 1997;52:413-418.
29. Di Q, Summers J, Burch JB, Mason WS: Major differences between WHV and HBV in the regulation of transcription. Virology 1997;229: 25-35.
30. Ueda K, Wei Y, Ganem D: Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II. J Virol 1996;70:4714-4723.
31. Wei Y, Tennant B, Ganem D: In vivo effects of mutations in woodchuck hepatitis virus enhancer II. J Virol 1998;72:6608-6613.
32. Levrero M, Jean-Jean O, Balsano C, Will H, Perricaudet M: Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. Virology 1990;174:299-304.
33. Dandri M, Schirmacher P, Rogler CE: Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol 1996;70:5246-5254.
34. Dandri M, Petersen J, Stockert RJ, Harris TM, Rogler CE: Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework. J Virol 1998;72:9359-9364.
35. Murakami S, Cheong JH, Kaneko S: Human hepatitis B virus X gene encodes a regulatory domain which represses transactivation of X protein. J Biol Chem 1994 269:15118-15123.
36. Cheong JH, Yi MK, Lin Y, Murakami S: Human RPB5, a Subunit shared by eukaryotic nuclear polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J. 1995;14:143-150.
37. Wang WL, London WT, Lega L, Feitelson MA: HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 1991;14:29-37.
38. Su Q, Schroder CH, Holmann WJ, Otto G, Pichlmayr R, Bannasch P: Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998;27:1109-1120.
39. Doria M, Klein N, Lucito R, Schneider RJ: The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995;14:4747-4757.
40. Sirma H, Weil R, Rosmordue O, Urban S, Israel A, Kremsdorf D, Brechot C: Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene 1998;16:2051-2063.
41. Haviv I, Shamay M, Doitsh G, Shaal Y: Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol 1998;18:1562-1569.
42. Nomura T, Lin Y, Dorjsuren D, Ohno S, Yamashita T, Murakami S: Human Hepatitis B virus X protein is detectable in nuclei of transfected cells, and active for transactivation. Biochim Biophys Acta 1999;1453:330-340.
43. Seto E, Mitchell PJ, Yen TS: Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 1990;344:72-74.
44. Lin Y, Tang H, Nomura T, Hayashi N, Dorjsuren D, Ohta T, Reoder R, Murakami S: The HBV X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators. J Biol Chem 1998;273:27097-27103.
45. Lin MH, Lo SC: Dimerization of hepatitis B viral X protein synthesized in a cell-free system. Biochem Biophys Res Commun 1989;164:14-21.
46. Schek N, Bartenschlager R, Kuhn C, Schaller H: Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 1991;6:1735-1744.
47. Gupta A, Mal TK, Jayasuryan N, Chauhan VS: Assignment of disulphide bonds in the X protein (HBx) of hepatitis B virus. Biochem Biophys Res Commun 1995;212:919-924.
48. Urban S, Hildt E, Eckerskorn C, Sirma H, Kekule A, Hofschneider PH: Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system. Hepatology 1997;26:1045-1053.
49. Takada S, Koike K: X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn J Cancer Res 1990;81:1191-1194.
50. Laskowski M Jr, Kato I: Protein inhibitors of proteinases. Annu Rev Biochem 1980;49:593-626.
51. Kim YH, Kang SK, Lee YI: Functional analysis of hepatitis B virus transactivator X: Implication of the leucine zipper-like region and C-terminal seven conserved amino acids in functional regions. Biochem Biophys Res Commun 1993;197:894-903.
52. Takada S, Kido H, Fukutomi A, Mori T, Koike K: Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. Oncogene 1994;9:341-348.
53. Runkel L, Fischer M, Schaller H: Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function. Virology 1993;197:529-536.
54. Kumar V, Jayasuryan N, Kumar R: A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci USA 1996;93:5647-5652.
55. Semmes OJ, Jeang KT: Mutational analysis of human T-cell leukemia virus type I Tax: Regions necessary for function determined with 47 mutant proteins. J Virol 1992;66:7183-7192.
56. Huang J, Kwong J, Sun EC, Liang TJ: Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol 1996;70: 5582-5591.
57. Lin Y, Nomura T, Cheong JH, Dorjsuren D, Iida K, Murakami S: Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor TFIIB and the RNA polymerase subunit RPB5. J Biol Chem 1997;272:7132-7139
58. De-Medina T, Shaul Y: Functional and structural similarity between the X protein of hepatitis B virus and nucleoside diphosphate kinases. FEBS Lett 1994;351:423-426.
59. Qadri I, Ferrari ME, Siddiqui A: The hepatitis B virus transactivator protein, HBx, interacts with single-stranded DNA (ssDNA). Biochemical characterizations of the HBx-ssDNA interactions. J Biol Chem 1996;271:15443-15450.
60. Shimazu T, Takada S, Ueno Y, Hayashi Y, Koike K: Post-transcriptional control of the level of mRNA by hepatitis B virus X gene in the transient expression system using human hepatic cells. Genes Cells 1998;3:477-484.
61. Spandau DF, Lee CH: Transactivation of viral enhancers by the hepatitis B virus X protein. J Virol 1988;62:427-434.
62. Zahm P, Hofschneider PH, Koshy R: The HBV X-ORF encodes a transactivator: A potential factor in viral hepatocarcinogenesis. Oncogene 1988;3:169-177.
63. Twu JS, Robinson WS: Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci USA 1989;86: 2046-5200.
64. Aufiero B, Schneider RJ: The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J 1990;9: 497-504.
65. Wang HD, Trivedi A, Johnson DL: Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol 1998;18:7086-7094.
66. Cross JC, Wen P, Rutter WJ: Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A 1993;90:8078-8082.
67. Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, Natoli G, Briand P, Levrero M: Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol 1994;21: 103-109.
68. Maguire HF, Hoeffler JP, Siddiqui A: HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991;252:842-824.
69. Williams JS, Andrisani OM: The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci USA 1995;92:3819-3823.
70. Barnabas S, Hai T, Andrisani OM: The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem 1997;272: 20684-20690.
71. Yoo YD, Ueda H, Park K, Flanders KC, Lee YI, Jay G, Kim SJ: Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest 1996;97:388-395.
72. Zhou DX, Taraboulos A, Ou JH, Yen TS: Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol 1990;64:4025-4028.
73. Hu KQ, Vierling JM, Siddiqui A: Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc Natl Acad Sci USA 1990; 87:7140-7144.
74. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S: Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 1991;266: 13579-13763.
75. Twu JS, Lai MY, Chen DS, Robinson WS: Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 1993;192: 346-350.
76. Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Will H, Perricaudet M, Levrero M: Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level. Biochem Biophys Res Commun 1991;176:985-992.
77. Avantaggiati ML, Natoli G, Balsano C, Chirillo P, Artini M, De Marzio E, Collepardo D, Levrero M: The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene 1993;8:1567-1574.
78. Menzo S, Clementi M, Alfani E, Bagnarelli P, Iacovacci S, Manzin A, Dandri M, Natoli G, Levrero M, Carloni G: Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology 1993; 196:878-882.
79. Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E, Pivel JP, Lopez-Cabrera M, Fernandez-Ruiz E, Sanchez-Madrid F: Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-848.
80. Choi BH, Park CJ, Rho HM: Insulin activates the hepatitis B virus X gene through the activating protein-1 binding site in HepG2 cells. DNA Cell Biol 1998;17:951-956.
81. Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR: The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4. Oncogene 1998;16:2367-2380.
82. Doong SL, Lin MH, Tsai MM, Li TR, Chuang SE, Cheng AL: Transactivation of the human MDR1 gene by hepatitis B virus X gene product. J Hepatol 1998;29:872-878.
83. Wang HD, Yuh CH, Dang CV, Johnson DL: The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. Mol Cell Biol 1995;15:6720-6728.
84. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH: Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993;361:742-745.
85. Lucito R, Schneider RJ: Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 1992;66:983-991.
86. Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A, Balsano C, Levrero M: Ras-and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994;9:2837-2843.
87. Benn J, Schneider RJ: Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994;91: 10350-10354.
88. Benn J, Su F, Doria M, Schneider RJ: Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 1996;70:4978-4985.
89. Su F, Schneider RJ: Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 1996;70:4558-4566.
90. Klein NP, Schneider RJ: Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 1997;17:6427-6436.
91. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G: Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 1996;70:641-646.
92. Wang HD, Trivedi A, Johnson DL: Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol 1997;17:6838-6846.
93. Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, Garcia-Monzon C, Moreno-Olero R, Levrero M, Lopez-Cabrera M: The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology 1998;28:1013-1021.
94. Lara-Pezzi E, Armesilla AL, Majano PL, Redondo JM, Lopez-Cabrera M: The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway. EMBO J 1998;17:7066-7077.
95. Lee YH, Yun Y: HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 1998;273:25510-25515.
96. Antunovic J, Lemieux N, Cromlish JA: The 17 kDa HBx protein encoded by hepatitis B virus interacts with the activation domains of Oct-1, and functions as a coactivator in the activation and repression of a human U6 promoter. Cell Mol Biol Res 1993;39:463-482.
97. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC: Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230-2234.
98. Haviv I, Vaizel D, Shaul Y: The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 1995;15:1079-1085.
99. Haviv I, Vaizel D, Shaul Y: pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J 1996;15:3413-3420.
100. Haviv I, Matza Y, Shaul Y: pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants. Genes Dev 1998;12:1217-1226.
101. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S: The transactivation and p53-interaction functions of HBx are mutually interfering but distinct. Cancer Res 1997;57:5137-5142.
102. Dorjsuren D, Lin Y, Wei WX, Yamashita T, Nomura T, Hayashi N, Murakami S: RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol 1998;18:7546-7555.
103. Chou S, Struhl K: Transcriptional activation by TFIIB mutants that are severely impaired in interaction with promoter DNA and acidic activation domains. Mol Cell Biol 1997;17: 6794-6802.
104. Hosono S, Chou MJ, Lee CS, Shih C: Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene 1993;8:491-496.
105. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G: Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995;9: 41-47.
106. Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Jones R, Borkowski A, Harris CC: Integrity of p53 in hepatitis Bx antigen-positive and -negative hepatocellular carcinomas. Cancer Res 1997;57:426-432.
107. Takada S, Kaneniwa N, Tsuchida N, Koike K: Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 1997;15:1895-1901.
108. Feitelson MA, Zhu M, Duan LX, London WT: Hepatitis Bx antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993;8:1109-1117.
109. Feitelson MA, Ranganathan PN, Clayton MM, Zhang SM: Partial characterization of the woodchuck tumor suppressor, p53, and its interaction with woodchuck hepatitis virus X antigen in hepatocarcinogenesis. Oncogene 1997;15:327-336.
110. Truant R, Greenblatt J, Prives C, Cromlish JA: Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 1995;69:1851-1859.
111. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC: Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997;94:14707-14712.
112. Schaefer S, Seifer M, Grimmsmann T, Fink L, Wenderhold S, Hohne MW, Gerlich WH: Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein. J Gen Virol 1998;79:767-777.
113. Lee H, Lee YH, Huh YS, Moon H, Yun Y: X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/ core promoter. J Biol Chem 1995;270:31505-31512.
114. Takada S, Kaneniwa N, Tsuchida N, Koike K: Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system. Virology 1996;216: 80-89.
115. Prost S, Ford JM, Taylor C, Doig J, Harrison DJ: Hepatitis Bx protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. J Biol Chcm 1998;273:33327-33332.
116. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA: p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998;17:2115-2123.
117. Qadri I, Conaway JW, Conaway RC, Schaack J, Siddiqui A; : Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci USA 1996;93:10578-10583.
118. Lee TH, Elledge SJ, Butel JS: Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 1995;69: 1107-1114.
119. Becker SA, Lee TH, Butel JS, Slagle BL: Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 1998;72:266-272.
120. Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, Transy C: Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol 1997;71:6194-6199.
121. Lin GY, Paterson RG, Richardson CD, Lamb RA: The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 1998;249:189-200.
122. Fischer M, Runkel L, Schaller H: HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes 1995;10:99-102.
123. Melegari M, Scaglioni PP, Wands JR: Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 1998;72:1737-1741
124. Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto L: XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 1996;24:4741-4750.
125. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH: Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 1998;18:978-988.
126. Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E: The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein. J Biol Chem 1997;272:16482-16489.
127. Sun BS, Zhu X, Clayton MM, Pan J, Feitelson MA: Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen. Hepatology 1998;27: 228-239.
128. Oh S, Kim N, Lee Y: Identification of differentially expressed genes in human hepatoblastoma cell line (HepG2) and HBV-X transfected hepatoblastoma cell line (HepG2-4x). Mol Cells 1998;8:212-218.
129. Blum HE, Zhang ZS, Galun E, von Weizsäcker F, Garner B, Liang TJ, Wands JR: Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 1992;66: 1223-1227.
130. Koike K, Moriya K, Yotsuyanagi H, Iino S, Kurokawa K: Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 1994;94:44-49.
131. Benn J, Schneider RJ: Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA 1995;92: 11215-11219.
132. Kim H, Lee H, Yun Y: X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-385.
133. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC: Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;55:6012-6016.
134. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, Levrero M: The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997;94:8162-8167.
135. Su F, Schneider RJ: Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-8749.
136. Gottlob K, Fulco M, Levrero M, Graessmann A: The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 1998;273: 33347-33353.
137. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K: High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis In transgenic mice. Hepatology 1994;19:810-819.
138. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-1067.
139. Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, Natoli G, Briand P, Levrero M: Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol 1994;21: 103-109.
140. Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS: Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 1996;15:261-269.
141. Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, Buendia MA: The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997;14:395-404.
142. Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spindler G, Kock J, Schlicht HJ: Long-term expression of the hepatitis B virus core-e-and X-proteins does not cause pathologic changes in transgenic mice. J Hepatol 1997;26:119-130.
143. Yul DY, Moon HB, Son JK, Jeong SK, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK: Incidence of hepatocellular carcinoma in the transgenic mice expressing hepatitis B virus X-protein. J Hepatol, in press.
144. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kohayashi M, Koike K: The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 1989;80:617-621.
145. Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH: Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 1990;9:1137-1145.
146. Luber B, Arnold N, Sturzl M, Hohne M, Schirmacher P, Lauer U, Wienberg J, Hofschneider PH, Kekule AS: Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. Oncogene 1996;12:1597-1608.
147. Oguey D, Dumenco LL, Pierce RH, Fausto N: Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Hepatology 1996;24: 1024-1033.
148. Gottlob K, Pagano S, Levrero M, Graessmann A: Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Res 1998;58:3566-3570.
149. Ori A, Zauberman A, Doitsh G, Paran N, Oren M, Shaul Y: p53 binds and represses the HBV enhancer: An adjacent enhancer element can reverse the transcription effect of p53. EMBO J 1998;17:544-553.
150. Raney AK, Johnson JL, Palmer CN, McLachlan A: Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol 1997;71:1058-1071.
151. Hu KQ, Yu CH, Vierling JM: Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci USA 1992;89:11441-11445.
152. Zhou MX, Watabe M, Watabe K: The X-gene of human hepatitis B virus transactivates the c-jun and alpha-fetoprotein genes. Arch Virol 1994;134:369-378.
153. Lee Y, Park US, Choi I, Yoon SK, Park YM, Lee YI: Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin Cancer Res 1998;4: 1711-1717.
154. Flajolet M, Gegonne A, Ghysdael J, Tiollais P, Buendia MA, Fourel G: Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors. Oncogene 1997;15:1103-1110.